“ID: 2036 Next-generation sequencing to evaluate frequency of BCR-ABL1 kinase domain Imatinib-resistance mutations” (2017) Biomedical Research and Therapy, 4(S), p. S67. doi:10.15419/bmrat.v4iS.275.